Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation | Zendy

Pierre Jaı̈s | Zendy; B Cauchemez | Zendy; Laurent Macle | Zendy; Emile G. Daoud | Zendy; Paul Khairy | Zendy; Rajesh N. Subbiah | Zendy; Mélèze Hocini | Zendy; Fabrice Extramiana | Zendy; Frédéric Sacher | Zendy; Pierre Bordachar | Zendy; George J. Klein | Zendy; Rukshen Weerasooriya | Zendy; Jacques Clémenty | Zendy; Michel Haı̈ssaguerre | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation

Author(s) -

Pierre Jaı̈s,

B Cauchemez,

Laurent Macle,

Emile G. Daoud,

Paul Khairy,

Rajesh N. Subbiah,

Mélèze Hocini,

Fabrice Extramiana,

Frédéric Sacher,

Pierre Bordachar,

George J. Klein,

Rukshen Weerasooriya,

Jacques Clémenty,

Michel Haı̈ssaguerre

Publication year - 2008

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.108.772582

Subject(s) - medicine , atrial fibrillation , ablation , catheter ablation , pulmonary vein , cardiology , randomized controlled trial , quality of life (healthcare) , clinical endpoint , quinidine , multicenter trial , crossover study , anesthesia , multicenter study , nursing , alternative medicine , pathology , placebo

The mainstay of treatment for atrial fibrillation (AF) remains pharmacological; however, catheter ablation has increasingly been used over the last decade. The relative merits of each strategy have not been extensively studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research